What one share of Immutep Limited holds
Immutep is a late-stage biotechnology company developing novel LAG-3 related immunotherapies for cancer and autoimmune disease. We are pioneers in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3).
Immutep Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-06-30; the balance sheet is as of 2025-06-30.
| Sales | $0.92 |
|---|---|
| Profit | −$5.47 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$5.53 |
| Cash and investments | $6.07 |
| Book value | $12.93 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $5.36 | −$4.38 | $0.01 | −$3.53 | — | $9.41 |
| 2021 | $1.00 | −$7.51 | $0.00 | −$4.43 | — | $14.68 |
| 2022 | $1.16 | −$5.51 | $0.00 | −$5.17 | — | $15.00 |
| 2023 | $0.78 | −$6.02 | $0.01 | −$5.35 | — | $15.32 |
| 2024 | $0.86 | −$4.66 | $0.00 | −$3.80 | — | $17.42 |
| 2025 | $0.92 | −$5.47 | $0.00 | −$5.53 | — | $12.93 |
Common questions about Immutep Limited
How much does one share of Immutep Limited earn?
Over its latest fiscal year, Immutep Limited lost $5.47 for each share on $0.92 of sales.
Does Immutep Limited pay a dividend?
Immutep Limited didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Immutep Limited’s book value per share?
Immutep Limited’s book value is $12.93 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2025.
How much cash and debt does each share of Immutep Limited have?
Each share of Immutep Limited has $6.07 of cash and investments, as of June 30, 2025.
What is Immutep Limited’s free cash flow per share?
−$5.53 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Immutep Limited bought back shares?
Immutep Limited’s share count rose about 253% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.